GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stake Raised by Bremer Bank National Association

Bremer Bank National Association grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 15.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 73,940 shares of the company's stock after purchasing an additional 10,107 shares during the period. Bremer Bank National Association's holdings in GE HealthCare Technologies were worth $5,968,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in GEHC. CoreFirst Bank & Trust acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $25,000. Runnymede Capital Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $28,000. LGT Financial Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 46.2% in the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after acquiring an additional 123 shares during the period. Accredited Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $30,000. Finally, Ameriflex Group Inc. acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $31,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Trading Up 0.1%

Shares of GE HealthCare Technologies stock traded up $0.07 during trading hours on Friday, reaching $71.62. 2,152,672 shares of the company's stock were exchanged, compared to its average volume of 3,439,902. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $32.79 billion, a price-to-earnings ratio of 16.54, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company has a fifty day moving average of $68.01 and a 200-day moving average of $78.69. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.10. The company had revenue of $4.78 billion during the quarter, compared to the consensus estimate of $4.66 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company's revenue was up 2.7% on a year-over-year basis. During the same period last year, the firm earned $0.90 earnings per share. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies declared that its Board of Directors has initiated a share buyback program on Wednesday, April 30th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 3.1% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's leadership believes its stock is undervalued.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Friday, April 25th were issued a $0.035 dividend. The ex-dividend date was Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.20%. GE HealthCare Technologies's dividend payout ratio is currently 2.95%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Morgan Stanley lowered their price target on GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Wells Fargo & Company lowered their target price on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a report on Thursday, May 1st. Citigroup lowered their target price on GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a report on Wednesday, April 30th. UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and lowered their target price for the company from $74.00 to $73.00 in a report on Monday, May 5th. Finally, BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the company a "buy" rating in a report on Monday, April 14th. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $88.27.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.